The dopamine system plays a significant role in motor function and associative learning (1, 2). Dysfunction in dopamine signaling has been implicated in many neuropsychiatric disorders, such as Parkinson's disease, schizophrenia, attention deficit hyperactivity disorder, and drug abuse. One mechanism that underlies the dopaminergic regulation of cellular physiology involves modulation of ion channel activity and associated short-term changes in cellular excitability (3-6). Another mechanism involves regulation of gene expression, which can produce long-term changes in synaptic plasticity (7, 8) .
The dopamine system plays a significant role in motor function and associative learning (1, 2) . Dysfunction in dopamine signaling has been implicated in many neuropsychiatric disorders, such as Parkinson's disease, schizophrenia, attention deficit hyperactivity disorder, and drug abuse. One mechanism that underlies the dopaminergic regulation of cellular physiology involves modulation of ion channel activity and associated short-term changes in cellular excitability (3) (4) (5) (6) . Another mechanism involves regulation of gene expression, which can produce long-term changes in synaptic plasticity (7, 8) .
Dopamine acts through the D 1 and D 2 subfamilies of G-protein-coupled receptors. Many antipsychotic drugs, which are D 2 receptor antagonists, can induce gene expression (9) , suggesting that D 2 receptors, like D 1 receptors (10) (11) (12) , are important in gene regulation. Previous studies have shown that D 1 and D 2 dopamine receptors synergistically activate immediate early gene expression and locomotion in dopaminedepleted striatum (13, 14) . This D 1 -D 2 synergy indicates that D 2 receptors may achieve these effects through mechanisms other than that of reducing cAMP formation. One such possible mechanism is to elevate intracellular calcium (15) .
Two potential targets for D 2 receptors are the mitogenactivated protein kinase (MAPK) and the cAMP response element-binding protein (CREB). MAPKs are a family of serine͞threonine kinases that regulate multiple cellular responses including gene expression, and many MAPK substrates are transcription factors (16) . The extracellular signalregulated MAPK (ERK) is phosphorylated at Thr202͞Tyr204 by a wide variety of stimuli, such as Ca 2ϩ , growth factors, and neurotransmitters (17) (18) (19) . CREB is a plasticity-associated transcription factor that regulates the expression of many downstream genes containing CRE elements, such as c-fos (20, 21) . CREB is phosphorylated at Ser-133 by multiple protein kinases, including protein kinase A (PKA) and Ca 2ϩ ͞calmod-ulin-dependent protein kinases II and IV (CaMK) (22) (23) (24) . In the present study, we provide evidence that D 2 receptors can regulate gene expression by coupling to the Gq͞PLC␤ pathway, causing an elevation of intracellular Ca 2ϩ and activation of PKC, leading to the phosphorylation and activation of MAPK and CREB. Because MAPK and CREB signaling cascades are critical for neuronal plasticity and memory formation (25), our results provide a possible mechanism for long-term actions of D 2 receptors.
MATERIALS AND METHODS
Preparation and Treatment of Brain Slices. Four-week-old male Sprague-Dawley rats or C57BL͞6J mice were anesthetized and decapitated. Brains were quickly removed, iced, and blocked for slicing. Sagital sections (400 m) of the brain (cerebellum removed) were cut with a Vibratome Technical Products International (St. Louis). The major brain areas in the slices included neocortex, striatum, hippocampus, thalamus, and substantia nigra. The slices were bathed in a low Ca 2ϩ Hepes-buffered Insoluble material was removed by centrifugation (13,000 ϫ g for 10 min), and protein concentration for each sample was measured. Equal amounts of protein from slice homogenates were separated on 7.5% acrylamide gels and were transferred to nitrocellulose membranes. The blots were blocked with 5% nonfat dry milk for 1 hour at room temperature. Then the blots were incubated with phospho-p44͞42 MAPK (Thr202͞ Tyr204) antibody (New England Biolabs, 1:1,000) or phospho-CREB (Ser133) antibody (New England Biolabs, 1:1,000) for 1 hour at room temperature. After being rinsed, the blots were incubated with horseradish peroxidase-conjugated anti-mouse or anti-rabbit antibodies (Amersham Pharmacia, 1:2,000) for 1 hour at room temperature. After three washes, the blots were exposed to the enhanced chemiluminescence substrate. Then the blots were stripped for 1 hour at 50°C followed by saturation in 5% nonfat dry milk and were incubated with antibodies recognizing total MAPK and CREB. Quantitation was obtained from densitometric measurements of immunoreactive bands on autoradiograms. Data correspond to the mean Ϯ SEM of 3-10 samples per condition and were analyzed by paired t test. Pyk2 Immunoprecipitation. After incubation, slices were immediately lysed in lysis buffer (in mM: 1% Triton X-100, 5 EDTA, 10 Tris, 50 NaCl, 30 Na 4 P 2 O 7 ⅐10H 2 O, 50 NaF, and 0.1 Na 3 VO 4 ) on ice for 30 min. Cell lysates were centrifuged (15,000 ϫ g, 20 min) and ultracentrifuged (40,000 ϫ g, 1 hr) to remove insoluble material. Pyk2 antibody (Upstate Biotechnology, Lake Placid, NY, 1:1,000) was added to the homogenates and was incubated for 1 hour at 4°C. Protein ASepharose beads then were added and mixed for 1 hour at 4°C. The beads were pelleted by centrifugation and were washed three times with lysis buffer. After the final wash, the beads were resuspended in 50 l of a SDS͞PAGE sample buffer (50 mM Tris-HCl, pH 6.7͞10% glycerol͞2% SDS͞10% 2-mercaptoethanol͞0.01% bromophenol blue). Proteins were separated by SDS͞PAGE and were subjected to Western blotting with the anti-pY antibody (Upstate Biotechnology, 1:1,000) for the detection of tyrosine phosphorylation of Pyk2.
RESULTS
Effect of D 2 Dopamine Receptor Activation on Phosphorylation of MAPK and CREB. Brain slices were incubated with the D 2 receptor agonist quinpirole and were Western blotted with phospho-MAPK (Thr202͞Tyr204) or phospho-CREB (Ser133) antibody, followed by reblotting with antibodies that recognize total (phosphorylation-state independent) MAPK and CREB levels.
Application of quinpirole induced the phosphorylation of MAPK ( Fig. 1 A and B ) in brain slices. This effect was blocked by the D 2 antagonist eticlopride, confirming mediation by D 2 dopamine receptors. The D 2 -induced phosphorylation of MAPK showed rapid and transient kinetics, reaching a peak within 5 to 15 min and returning to basal level within 35 min (Fig. 1C) . The dose-dependence of quinpirole-induced MAPK phosphorylation is shown in Fig. 1D . A saturating effect was seen at 10 M. Total MAPK showed no change with any drug treatment (data not shown).
Treatment of brain slices with quinpirole also induced phosphorylation of CREB, and this effect was eliminated in the presence of the D 2 antagonist eticlopride ( Fig. 1 E and F) . lation of CREB showed rapid and transient kinetics, reaching a peak at 15 min and returning to basal level within 35 min (Fig.  1G) . The dose-dependence of CREB phosphorylation (Fig.  1H ) was similar to that of MAPK. Total CREB was not affected by any of these drug treatments (data not shown).
Signaling Pathways Underlying D 2 Receptor Regulation of MAPK Phosphorylation. In previous studies, it was found that Ca 2ϩ and PKC can activate the Ras͞Raf͞MEK͞MAPK signaling pathway in cell lines and neuronal cultures (17, 26) . We tested the possibility that D 2 receptors phosphorylate MAPK by coupling to the Gq͞PLC␤ pathway, which leads to the elevation of intracellular Ca 2ϩ and activation of PKC. For this purpose, the selective PKC inhibitor Go6976 and the intracellular Ca 2ϩ chelator BAPTA͞AM were used. Pretreatment of brain slices with Go6976 alone or BAPTA͞AM alone reduced the MAPK phosphorylation induced by quinpirole. Combined application of Go6976 and BAPTA͞AM abolished the ability of quinpirole to induce MAPK phosphorylation ( Fig. 2 A and B) . These results suggest that increases in intracellular Ca 2ϩ and activation of PKC both contribute to the D 2 induction of MAPK phosphorylation.
One possible mechanism by which D 2 receptors regulate MAPK phosphorylation in central nervous system neurons is by causing phosphorylation of the protein tyrosine kinase Pyk2, secondary to the elevation of intracellular Ca 2ϩ and activation of PKC, leading to activation of the MAPK signaling pathway (27) . Indeed, application of the D 2 agonist quinpirole induced the tyrosine phosphorylation of Pyk2, and this effect was blocked by the D 2 antagonist eticlopride (Fig. 2C) . To test whether the ability of D 2 receptors to induce MAPK phosphorylation was regulated through Pyk2, the broad-spectrum tyrosine kinase inhibitor genistein was used. If MAPK were the downstream target of Pyk2, pretreatment of brain slices with genistein should prevent the D 2 induction of MAPK phosphorylation. However, quinpirole still induced phosphorylation of MAPK in the presence of genistein (Fig. 2D) , indicating that D 2 receptor signaling can bypass Pyk2 to activate MAPK. Inhibiting the MAPK kinase (MEK) with PD98059 abolished the D 2 receptor-induced phosphorylation of MAPK (Fig. 2D) , indicating the involvement of MEK in this process.
Signaling Pathways Underlying D 2 Receptor Regulation of CREB Phosphorylation. In previous studies, it was found that CREB can be phosphorylated by multiple kinases in vitro, including PKA, PKC, CaMK, and the MAPK-activated Rsk family of protein kinases (22) (23) (24) 28) . To test which signaling molecules are responsible for the D 2 receptor-induced phosphorylation of CREB, selective protein kinase inhibitors were used. Inhibiting PKC with Go6976 or inhibiting CaMK with KN-93 did not block CREB phosphorylation induced by quinpirole (Fig. 3) . However, combined application of Go6976 and KN-93 eliminated the ability of quinpirole to induce CREB phosphorylation (Fig. 3) . These results suggest that the D 2 receptor-induced phosphorylation of CREB is caused by the combined activation of CaMK and PKC.
Because D 2 receptors can induce MAPK phosphorylation (shown above) and phospho-MAPK can indirectly activate CREB via Rsk family kinases (28), one potential pathway for the D 2 induction of CREB phosphorylation is through activated MAPK. To test this possibility, brain slices were pretreated with the MAPK kinase (MEK) inhibitor PD98059. As shown in Fig. 3 , the D 2 receptor-induced phosphorylation of CREB was not blocked by PD98059, although this compound blocked D 2 receptor-induced MAPK phosphorylation ( (15). Phosphorylation of DARPP-32 at Thr-34 converts it into a potent inhibitor of protein phosphatase 1 (31), thereby affecting the phosphorylation state and physiological activity of many downstream targets of protein phosphatase 1 (29) . To investigate whether DARPP-32 is involved in the mechanism by which D 2 receptors regulate MAPK and CREB phosphorylation, DARPP-32 knockout mice (30) were examined. The basal MAPK and CREB phosphorylation levels were elevated in slices from DARPP-32 Ϫ͞Ϫ mice. The D 2 -induced phosphorylation of MAPK and CREB was virtually abolished in DARPP-32 Ϫ͞Ϫ mice, compared with that in wild-type mice (Fig. 4) . The results indicate that DARPP-32 is an important component of the signaling cascades that mediate the D 2 receptor-induced phosphorylation of MAPK and CREB.
DISCUSSION
In this study, we demonstrated that the D 2 receptor agonist quinpirole can stimulate the phosphorylation and activation of MAPK and CREB, two molecules that are crucial for the induction of many immediate-early and late response genes. Signal transduction pathways involved in mediating these D 2 effects are illustrated in Fig. 5 . Elevated intracellular Ca 2ϩ , CaMK, PKC, and DARPP-32 are important components in these cascades.
MAPK is highly expressed in the nervous system (32) and is localized primarily in neuronal cell bodies and dendrites (33) , consistent with a postsynaptic function in neuronal signaling. In addition to being involved in gene expression, MAPK also regulates cytoskeleton dynamics and cytoplasmic signaling (34, 35) . Given the wide variety of downstream targets for MAPK, the D 2 activation of MAPK signaling potentially has a diverse array of physiological functions.
MAPK can be activated by a complex set of extracellular stimuli and intracellular molecules. In this study, we obtained evidence that D 2 receptor agonists, by increasing intracellular Ca protein synthesis, CREB can mediate the long-term remodeling of synapses, which is believed to underlie memory consolidation and neuronal plasticity. The D 2 receptorinduced activation of CREB signaling provides a potential mechanism for the effect of antipsychotic drugs on immediate early gene expression (12) and neural circuit rewiring.
It is known that CREB can be activated through multiple pathways. These include PKA, PKC, CaMK, and the MAPKactivated Rsk family of protein kinases (22) (23) (24) 28) . In some systems, MAPK activation was necessary for increased CREB phosphorylation (36, 37) . In the neurons studied here, activation of PKC and CaMK, but not MAPK, was responsible for the D 2 receptor-induced CREB phosphorylation.
The different subcellular localizations of MAPK and CREB signaling would be expected to result in activation of different downstream targets and physiological responses to D 2 receptors. MAPK phosphorylation occurs primarily in dendrites, regulating protein synthesis, cytoskeletal dynamics, and ion channel activities at synapses. On the other hand, CREB phosphorylation occurs in cell bodies, regulating gene expression in the nucleus.
One signaling component that seems to be critically involved in the D 2 receptor-induced phosphorylation of MAPK and CREB is DARPP-32. In DARPP-32 knockout mice, the basal phosphorylation levels of MAPK and CREB were elevated, and the ability of D 2 receptors to induce phosphorylation of MAPK and CREB was lost. DARPP-32 plays a central role in signal transduction in dopaminoceptive neurons (29) . Numerous first messengers regulate the phosphorylation state of DARPP-32. DARPP-32, in turn, regulates the phosphorylation and activity of many downstream effectors. Further studies will be necessary to determine the precise molecular mechanisms by which DARPP-32 regulates the phosphorylation of MAPK and CREB.
In conclusion, this study indicates that activation of D 2 receptors can lead to the phosphorylation and activation of MAPK and CREB in neurons. The results provide a potential molecular mechanism for some long-term effects of D 2 receptors, such as alterations of gene expression. Because D 1 receptors also can phosphorylate and activate CREB (10) (11) (12) and MAPK (38) , the present results provide a possible explanation for the synergistic effects of D 1 and D 2 dopamine receptors on immediate early gene induction in striatum (13, 14) . It remains for future studies to identify downstream targets that are regulated by these signaling cascades. The insight gained from these studies may be helpful for understanding the mechanisms underlying dopamine-related neurological disorders.
FIG. 5.
Model of signaling cascades involved in D2 receptorinduced phosphorylation of MAPK and CREB. In this model, D2 receptors couple to the Gq protein and activate PLC␤, which promotes the hydrolysis of phosphatidlyinositide biphosphate (PIP2) to form 1,2-diacylglycerol and 1,4,5-inositol trisphosphate. 1,2-diacylglycerol activates PKC, and 1,4,5-inositol trisphosphate causes the release of Ca 2ϩ from intracellular stores. PKC and Ca 2ϩ together activate Ras͞Raf͞MEK͞MAPK signaling through mechanisms independent of Pyk2. CaMK activated by elevation of intracellular Ca 2ϩ , together with activated PKC, phosphorylate CREB. DARPP-32 is involved in the D2 receptor regulation of phosphorylation of both MAPK and CREB. The mechanism by which this occurs most likely involves regulation by D2 receptors of the phosphorylation state of DARPP-32, and therefore of the activity of protein phosphatase 1 (29) 
